20/20 GeneSystems raises $4.5M in series A

Diagnostic play 20/20 GeneSystems Inc. (Rockville, Md.) raised $4.5 million in a series A round. Investors included Ping An Ventures, which is the venture capital division of China's largest insurance company, and affiliates of angel investor network Keiretsu Forum.

The company intends to customize its blood test for early detection of lung cancer for the Chinese market. 20/20 did not respond to inquiries. ...